biological_process

mitochondrial dysfunction

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about mitochondrial dysfunction: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3483Connections

1Hypotheses

4Analyses

50Outgoing

50Incoming

No summary available yet. View on Wiki →

🧬 Biological Process Info

Name	mitochondrial dysfunction
Key Genes/Proteins	APOE4
Related Diseases	Parkinson's Disease, Intervertebral Disc Degeneration, skeletal muscle atrophy, developmental toxicity
Related Pathways	PINK1/Parkin pathway
Linked Hypotheses	1 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

Pathway Diagram

graph TD
    mitochondrial_dysfunction["mitochondrial dysfunction"] -->|"causes"| neurodegeneration["neurodegeneration"]
    style neurodegeneration fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    mitochondrial_dysfunction["mitochondrial dysfunction"] -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
    style Alzheimer_s_disease fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    mitochondrial_dysfunction["mitochondrial dysfunction"] -->|"activates"| oxidative_stress["oxidative stress"]
    style oxidative_stress fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    mitochondrial_dysfunction["mitochondrial dysfunction"] -->|"associated"| Parkinson_s_disease["Parkinson's disease"]
    style Parkinson_s_disease fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    mitochondrial_dysfunction["mitochondrial dysfunction"] -->|"causes"| age_related_macular_degenerati["age-related macular degeneration"]
    style age_related_macular_degenerati fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    mitochondrial_dysfunction["mitochondrial dysfunction"] -->|"activates"| reactive_oxygen_species["reactive oxygen species"]
    style reactive_oxygen_species fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    mitochondrial_dysfunction["mitochondrial dysfunction"] -->|"causes"| neurodegenerative_disorders["neurodegenerative disorders"]
    style neurodegenerative_disorders fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    PS_NPs["PS-NPs"] -->|"causes"| mitochondrial_dysfunction["mitochondrial dysfunction"]
    style PS_NPs fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#e0e0e0
    melatonin["melatonin"] -->|"protects against"| mitochondrial_dysfunction["mitochondrial dysfunction"]
    style melatonin fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#e0e0e0
    defective_mitophagy["defective mitophagy"] -->|"causes"| mitochondrial_dysfunction["mitochondrial dysfunction"]
    style defective_mitophagy fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#e0e0e0
    GBA["GBA"] -->|"causes"| mitochondrial_dysfunction["mitochondrial dysfunction"]
    style GBA fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
    AGEs["AGEs"] -->|"causes"| mitochondrial_dysfunction["mitochondrial dysfunction"]
    style AGEs fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style mitochondrial_dysfunction fill:#5d4400,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold

Outgoing (2042)

Target	Relation	Type	Str
Parkinson's Disease	drives	disease	0.95
neuroinflammation	drives	process	0.95
neuronal energy failure	drives	process	0.95
Intervertebral Disc Degeneration	drives	disease	0.95
ATP depletion	causes	process	0.93
skeletal muscle atrophy	causes	phenotype	0.92
ROS overproduction	mediates	process	0.92
ROS overproduction	causes	process	0.92
developmental toxicity	mediates	phenotype	0.91
NF-κB	activates	pathway	0.90
epithelial-mesenchymal transition	triggers	process	0.90
SENESCENCE	induces	process	0.90
neurodegenerative disorders	drives	disease	0.90
oxidative stress	drives	process	0.90
endothelial function	associated_with	process	0.90
oxidative stress	promotes	process	0.90
neuronal apoptosis	promotes	process	0.90
PANoptosis	upstream_of	process	0.89
neuronal apoptosis	drives	process	0.88
neurodegeneration	causes	process	0.85
senescence	promotes	process	0.85
blood-brain barrier integrity	associated_with	process	0.85
Age-related hearing loss	contributes_to	disease	0.85
m6A deposition	inhibits	process	0.85
dopaminergic neuron loss	causes	phenotype	0.85
neuroinflammation	contributes_to	process	0.85
neurodegeneration	drives	process	0.85
Amyotrophic Lateral Sclerosis	contributes_to	disease	0.85
calcium dysregulation	causes	phenotype	0.85
apoptosis	activates	process	0.85
neuronal injury	contributes_to	phenotype	0.85
age-related hearing loss	contributes_to	disease	0.85
Alzheimer's Disease	contributes_to	disease	0.82
Purkinje cells	causes	cell_type	0.80
retinal toxicity	causes	disease	0.80
retinal toxicity	contributes_to	disease	0.80
cardiovascular diseases	implicated_in	disease	0.80
metabolic syndrome	implicated_in	disease	0.80
multiple sclerosis	implicated_in	disease	0.80
acute kidney injury	contributes_to	disease	0.80
mitophagy	activates	process	0.80
TFEB upregulation failure	causes (prevents energy needed for enhanced autophagy desp)	mechanism	0.80
lysosomal dysfunction	interacts_with	phenotype	0.75
genomic instability	promotes	phenotype	0.75
ALS	causes (mitochondrial dysfunction is central to ALS pathog)	disease	0.75
Alzheimer's disease	causes	disease	0.70
oxidative stress	activates	process	0.70
Parkinson's disease	associated_with	disease	0.70
Alzheimer's disease	associated_with	disease	0.70
Parkinson's disease	causes	disease	0.70

Incoming (1441)

Source	Relation	Type	Str
impaired mitophagy	causes	process	0.95
Ps-Cooh	causes	compound	0.95
PM10	causes	compound	0.95
microplastics and nanoplastics	causes	compound	0.95
APOE4	promotes	gene	0.94
PINK1/Parkin pathway	prevents	pathway	0.93
TFAM	protects_against	protein	0.91
PS-NPs	causes	drug	0.90
melatonin	protects_against	drug	0.90
defective mitophagy	causes	phenotype	0.90
GBA	causes	gene	0.90
mitophagy	prevents	process	0.90
IL17A	promotes	gene	0.90
NOTCH2NLC	causes	gene	0.90
APOPTOSIS	triggers	process	0.90
OXIDATIVE STRESS	critical_for	process	0.90
tau pathology	causes	process	0.90
AMPK	suppresses	protein	0.90
cerebral ischemia-reperfusion injury	causes	disease	0.90
MitoQ	protects_against	drug	0.89
microglia	associated_with	cell_type	0.88
MitoQ	associated_with	drug	0.88
antioxidant defenses	protects_against	process	0.88
reactive oxygen species production	mediates	process	0.88
SIRT1	prevents	protein	0.85
ErbB4	prevents	gene	0.85
NAD+ decline	causes	process	0.85
MFN2	contributes_to	gene	0.85
curcumin	associated_with	compound	0.85
Acetyl-L-Carnitine	treats	compound	0.85
methanol	causes	compound	0.85
SKQ1	treats	drug	0.85
vanadium	causes	compound	0.85
endoplasmic reticulum stress	contributes_to	process	0.85
mitochondrial dynamics imbalance	contributes_to	process	0.85
impaired mitophagy	contributes_to	process	0.85
GJ-PD herbal pair	associated_with	drug	0.82
AGEs	causes	protein	0.80
AMPK	modulates	protein	0.80
MAPK	regulates	pathway	0.80
neolignans	prevents	drug	0.80
MICROGLIA	mediates	cell_type	0.80
NEURONS	mediates	cell_type	0.80
OGD/R	induces	process	0.80
iPSC reprogramming	reverses	process	0.80
innate immune signaling	induces	process	0.80
metabolic disruption	induces	process	0.80
SIRT6	prevents	protein	0.80
CKLF	induces	protein	0.80
Isoliquiritigenin	ameliorates	compound	0.80

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
C1q Inhibition Prevents Synaptic Mitochondrial Dysfunction v	0.455	neurodegeneration	Why does PRKN-mediated mitophagy, typica

Mentioning Analyses (4)

Scientific analyses that reference this entity

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or c

neurodegeneration | 2026-04-11 | 0 hypotheses

Does TFEB dysfunction cause neurodegeneration or represent a compensatory respon

neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.510

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

neurodegeneration | 2026-04-03 | 34 hypotheses Top: 0.692

CRISPR-based therapeutic approaches for neurodegenerative diseases

neurodegeneration | 2026-04-03 | 14 hypotheses Top: 0.622

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

mitochondrial dysfunction

Understanding Entity Pages

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

Progressive Supranuclear Palsy (PSP)

Corticobasal Syndrome (CBS)

Novel Therapy Index

Parkinson's Disease

Sleep and Circadian Dysfunction in Alzheimer's Disease

Microglia CD8+ T Cell Recruitment -- Supplementary WW Content

CBS/PSP Supplements Guide

Atypical Parkinsonism

Parthanatos in Neurodegeneration

calcium-dysregulation-comparison

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Alpha-Synuclein Pathology

PD Combination Therapy Matrix

Alzheimer's Disease Mechanism Index

Corticobasal Degeneration (CBD)

nimodipine-als

Neuroresilience Mechanisms and Evidence

NPM1 Gene